Genmab A/S (LON:0MGB)
London
· Delayed Price · Currency is GBP · Price in DKK 1,286.75
-7.20 (-0.56%)
At close: Apr 16, 2025
Genmab Market Cap
Genmab has a market cap or net worth of 9.55 billion as of April 24, 2025. Its market cap has decreased by -37.79% in one year.
Market Cap
9.55B
Enterprise Value
7.25B
Revenue
2.39B
Ranking
n/a
PE Ratio
10.98
Stock Price
1,286.75
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 287.00M to 9.55B, an increase of 3,227.58%. That is a compound annual growth rate of 15.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.68B |
| HSBC Holdings | 148.30B |
| Shell | 146.96B |
| Unilever | 119.58B |
| Rio Tinto Group | 77.78B |
| RELX PLC | 72.64B |
| British American Tobacco p.l.c. | 69.69B |
| Rolls-Royce Holdings | 61.54B |